Key result
Onco-hypertension management requires a multidisciplinary approach involving oncologists, nephrologists, and cardiologists to minimize cardiovascular risks and optimize cancer treatment outcomes.
Why the study?
Uncontrolled high blood pressure in cancer patients increases cardiovascular complications and negatively impacts overall health.
Answers are grounded in this paper and cite their sources.
Effective management of cancer-associated hypertension requires a multidisciplinary approach to minimize cardiovascular complications without compromising oncologic treatment.
It is essential to manage hypertension in cancer patients because uncontrolled high blood pressure can increase the risk of cardiovascular complications and negatively impact overall health. We searched PubMed, Web of Science, EBSCO, Scopus, Google Scholar, Directory of Open Access Journals (DOAJ), and Embase, using keywords including; hypertension, onco-hypertension, and Neoplasms; and found that several factors can contribute to the development of onco-hypertension, including certain types of cancer, chemotherapy drugs, targeted therapies, and hormonal treatments. Favorable cooperation of multi-specialists in this disease treatment can lead to better and more optimal treatment management for these patients.
No takes yet. Share an insight, caveat, or question.
Sara Dehghan (2023) conducted a review in Onco-hypertension. Multidisciplinary management was evaluated. Onco-hypertension management requires a multidisciplinary approach involving oncologists, nephrologists, and cardiologists to minimize cardiovascular risks and optimize cancer treatment outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: